Neuromuscular Disorder-Targeting Compound 1 |
| Catalog No.GC31288 |
El compuesto 1 dirigido a trastornos neuromusculares se utiliza en la investigaciÓn de trastornos neuromusculares como los sÍntomas del sÍndrome de fibromialgia y el sÍndrome de fatiga crÓnica.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 374538-23-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome.
Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome[1].
[1]. Robertson, David W., et al. TREATMENT OF FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME. WO 2001087308 A1.
Average Rating: 5 (Based on Reviews and 20 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *